Cargando…
WWOX sensitises ovarian cancer cells to paclitaxel via modulation of the ER stress response
There are clear gaps in our understanding of genes and pathways through which cancer cells facilitate survival strategies as they become chemoresistant. Paclitaxel is used in the treatment of many cancers, but development of drug resistance is common. Along with being an antimitotic agent paclitaxel...
Autores principales: | Janczar, Szymon, Nautiyal, Jaya, Xiao, Yi, Curry, Edward, Sun, Mingjun, Zanini, Elisa, Paige, Adam JW, Gabra, Hani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550887/ https://www.ncbi.nlm.nih.gov/pubmed/28749468 http://dx.doi.org/10.1038/cddis.2017.346 |
Ejemplares similares
-
The Role of Histone Protein Modifications and Mutations in Histone Modifiers in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia
por: Janczar, Szymon, et al.
Publicado: (2017) -
Neonatal neuronal WWOX gene therapy rescues Wwox null phenotypes
por: Repudi, Srinivasarao, et al.
Publicado: (2021) -
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer
por: Sharma, Rohini, et al.
Publicado: (2011) -
Introduction to managing patients with recurrent ovarian cancer
por: Gabra, Hani
Publicado: (2014) -
WWOX Possesses N-Terminal Cell Surface-Exposed Epitopes WWOX(7-21) and WWOX(7-11) for Signaling Cancer Growth Suppression and Prevention In Vivo
por: Wang, Wan-Jen, et al.
Publicado: (2019)